Download PDF
1 / Pages

Other users also viewed these articles

Response to ¿Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis¿. Response to related letter José C. De La Flor; Esperanza Moral; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Miguel Rodeles;
Nefrologia (English Version). 2024;44:444-6
Hypochloremia associated with a greater incidence of pneumonia in chronic hemodialysis patients with COVID-19: a center's experience Francisco Valga; Tania Monzón; Nicanor Vega-Diaz; Sergio Ruiz-Santana; Sara Aladro; Rassoul Diallo-Saavedra; Jose Carlos De la Flor; José Carlos Rodriguez-Perez;
Nefrologia (English Version). 2024;44:290-2
Efficacy and safety of semaglutide in a diabetic and obese patient on incremental hemodialysis. Does it also contribute to preserving residual renal function? José Carlos de la Flor; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Elisa Ruiz; Miguel Rodeles;
Nefrologia (English Version). 2023;43:501-3